Quando in gioco vi è il benessere del paziente, l’innovazione dirompente è una continua preoccupazione e il guasto di un prodotto non è un'opzione accettabile nel settore biomedico.
L’applicazione della simulazione nello sviluppo può fare la differenza nel portare nuove cure ai pazienti e allo stesso tempo rispettare gli standard di sicurezza e la scadenza dei prodotti.
ncludendo l’affidabilità nel processo di sviluppo, si rispettano più facilmente gli standard sempre più stringenti imposti dalle normative e si salvano più vite. Dato che i test clinici non possono affrontare tutte le possibili situazioni, le aziende del settore biomedicale adottano la simulazione ingegneristica (testing in silico) per identificare e risolvere in modo sistematico i differenti scenari possibili.
- Hearts Content - Article - ANSYS Advantage - V10 I3
- Wired into Health - Article - ANSYS Advantage - V10 I2
- Cardiovascular Engineering - Article - ANSYS Advantage - V7 I2
- In Your Blood - Article - ANSYS Advantage - V8 I1
- Change of Heart - Article - ANSYS Advantage - V8 I2
- Cut to the Bone - Article - ANSYS Advantage - V5 I2
- A New System for Surgery - Article - ANSYS Advantage - V6 I1
- Engineering Solutions for Infection Control - Article - ANSYS Advantage - V1 I2
- Taming the Cost of Respiratory Drug Development - Article - ANSYS Advantage - V4 I2
- White Papers
- Using Computational Modeling to Control and Optimize the Crystallization Process - White Paper
- Engineering Simulation: A Promising Tool for Securing Regulatory Approvals - White Paper
- Leveraging Engineering Simulation to Fast-Track Personalized Healthcare - White Paper
- Digital System Prototyping for Medical Devices - White Paper
- 10 Compelling Reasons to Upgrade to ANSYS 17.0 for Healthcare Applications - Webinar
- Vertical Medical Applications: Bringing Simulation to Clinicians - Webinar
- What are Healthcare Thought Leaders Foreseeing for 2016 - Webinar
- Nonlinear Modeling for Health Care Applications - Webinar
- ANSYS Convergence Webinar Series 2013: Business of Simulation
- Assessment of Turbulent Blood Flow Using CFD
- Predicting MR Compliance of Implanted Devices
- Streamline Mixing Analysis and Enable Quality by Design Using ANSYS Workbench
Implantable cardiovascular devices — stents, coils, heart valves and pacemakers — are complex as a result of exacting product and regulatory (FDA) specifications. The study of hemodynamics is critical to cardiac device engineering, which can benefit greatly from engineering simulation and advanced fluid–structure interaction modeling.
As life expectancy rises, orthopedic researchers are extending the life of joint implants and developing innovative replacement therapies for aging hips, knees, shoulders and spines. Successful companies invest heavily in engineering simulation to develop the best possible design while ensuring implantable product reliability.
Diagnosis & Personalized Medicine
Engineering simulation is a proven way to optimize diagnostic equipment. The trend is toward smaller, smarter, more portable and more accurate devices.
Medical & Hospital Supplies
"Smart" medical equipment and supplies incorporate multifunctional electronic and microelectronic capabilities, which add complexity to the product engineering process.
Globalization addresses the lack of engineering resources in non-industrialized countries. It also enables the healthcare industry to customize global concepts (device, product or process) to meet local needs.
Affordable & Profitable Medicine
Affordable treatment and product profitability are not at odds: Successful healthcare companies streamline the long, costly testing and approval process yet still engineer innovative medical and pharmaceutical solutions.
Ensuring Extreme Reliability
Regulatory approval includes subjecting products, procedures and services to the extreme conditions they will encounter during use — over a large patient population. ANSYS technology helps minimize the chance that a medical device will fail, not just for regulatory testing but throughout its lifetime.
Boosting Medical Innovation
Despite shrinking budgets, leading medical device companies push innovation to the limit, fueled by the demand for new and cheaper medical solutions, an aging population and growing access to care.